• Private Equity Firm

    Shavit Capital is an investment firm that specializes in late-stage investments in Israeli companies.

    Shavit Capital has over $200 million under management across four separate private equity funds. Shavit Capital was founded in 2008 and the fourth fund was raised in 2017.  These Funds invest in Israeli companies with proven technologies, products, markets and strong management teams. The Funds invest in equity mezzanine or bridge rounds in companies which subsequently expect to raise relatively larger amounts pursuant to an IPO on a major international public exchange or a dual listing of a company that trades on the Tel Aviv Stock Exchange.

    Shavit Capital also invests in other late-stage opportunities, especially through PIPEs (Private Investment in Public Equites) of Israeli publicly-traded companies.

  • Company News

    Foamix Announces Plans for Additional Phase 3 Trial for Acne Product
    May 1, 2017
    Intec Appoints Jeffrey A. Meckler to its Board of Directors
    April 9, 2017
    Intec Initiates Phase I of Accordion Pill for Cannabinoid Therapies
    March 22, 2017
    FDA חברת פוליפיד הישראלית נכנסה למסלול מזור
    March 13, 2017
    FDA fast tracks Israeli co PolyPid
    March 13, 2017
    Intec Pharma raises $10m in private placement
    March 12, 2017
    PolyPid Announces Positive Interim Data for BonyPid 1000
    March 9, 2017
    Foamix Year End 2016 Financial Results and Business Update
    February 22, 2017
    ReWalk Robotics Reports 4Q and Year-End 2016 Results
    February 17, 2017
    Israeli Drugmaker Foamix Spots Lucrative Gap in Acne Market
    December 19, 2016